scispace - formally typeset
L

Luis Lasalvia

Researcher at Siemens

Publications -  24
Citations -  310

Luis Lasalvia is an academic researcher from Siemens. The author has contributed to research in topics: Ejection fraction & Cost effectiveness. The author has an hindex of 7, co-authored 24 publications receiving 220 citations.

Papers
More filters
Journal ArticleDOI

Galectin-3 levels are associated with right ventricular functional and morphologic changes in pulmonary arterial hypertension.

TL;DR: Serum Gal-3 levels are associated with multiple indices of RV function and morphology, and may represent a novel biomarker for RV remodeling and associated ECM turnover in PAH.
Journal ArticleDOI

Gene-expression signature of tumor recurrence in patients with stage II and III colon cancer treated with 5'fluoruracil-based adjuvant chemotherapy.

TL;DR: Identification of a new gene‐expression signature associated with a high probability of tumor recurrence in patients with Stages II and III colon cancer receiving adjuvant 5FU‐based chemotherapy, and its combination in a robust, easy‐to‐use and reliable algorithm may contribute to tailor treatment and surveillance strategies.
Journal ArticleDOI

Cystatin C: a potential biomarker for pulmonary arterial hypertension.

TL;DR: Cystatin C, a novel marker of renal function, predicts left heart failure and cardiovascular mortality and the hypothesis that serum CysC levels correlate with right ventricular morphology, function and pressure in pulmonary arterial hypertension was tested.
Journal ArticleDOI

Cost-effectiveness of enhanced liver fibrosis test to assess liver fibrosis in chronic hepatitis C virus and alcoholic liver disease patients

TL;DR: The use of the ELF test with or without a confirmation LSM are cost-effective options compared to a single liver biopsy for testing liver fibrosis in HCV and ALD patients in Spain.